Abstracts - Association for Chemoreception Sciences
Abstracts - Association for Chemoreception Sciences
Abstracts - Association for Chemoreception Sciences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
This interplay could be mediated by neuroendocrine signals like<br />
insulin and/or leptin as their receptors have been described at<br />
peripheral (olfactory epithelium) and central (olfactory bulb, OB)<br />
levels. To test this hypothesis, we studied the modulation of the<br />
activity of the olfactory sensory neurons (OSN) by hormonal<br />
peptides. Using patch-clamp recordings in an in vitro intact<br />
epithelium, we showed that insulin- or leptin-perfusion<br />
significantly raises the spontaneous firing frequency of the OSN.<br />
Moreover, these hormones decrease the OSN transduction<br />
current and receptor potential recorded during odorant<br />
stimulation. There<strong>for</strong>e by increasing the spontaneous activity but<br />
reducing the odorant-induced activity of OSN, an elevated insulin<br />
and leptin level may result in a decreased global signal to-noise<br />
ratio in the olfactory epithelium. This input to the bulb is further<br />
modulated by the main output neurons of the OB (mitral cells,<br />
MC). The MC are one of the central targets of these hormones:<br />
MC express insulin receptors and their discharge is modulated by<br />
insulin or leptin. This effect would underlie our behavioral tests<br />
where an icv injection of either insulin or leptin decreases<br />
olfactory detection. Thus insulin and leptin act in the olfactory<br />
system both at peripheral and OB levels to modulate olfactory<br />
sensitivity. The role of olfaction in the control of food intake<br />
appears crucial and needs to be investigated further in order to<br />
better understand alimentary pathologies. Acknowledgements:<br />
This grant was supported by the Agence Nationale de la<br />
Recherche (ANR), the French national research agency (project<br />
ANR-05-PNRA-1.E7 AROMALIM)<br />
#37 SYMPOSIUM - CHEMORECEPTION<br />
IN CONTEXT: INTERACTIONS WITH<br />
ENDOCRINE SYSTEMS AND METABOLIC STATE<br />
The olfactory bulb as a metabolic sensor via insulin modulation<br />
Debra A. Fadool 1,2 , Kristal Tucker 2 , David R. Marks 2 , Melissa A.<br />
Cavallin 2 , James M. Overton 3 , Paola Pedarzani 4<br />
1<br />
Florida State University Program in Neuroscience and Molecular<br />
Biophysics Tallahassee, FL, USA, 2 Florida State University<br />
Department of Biological <strong>Sciences</strong> Tallahassee, FL, USA, 3 Florida<br />
State University Department of Biomedical <strong>Sciences</strong> and Program<br />
in Neuroscience Tallahassee, FL, USA, 4 Research Department of<br />
Neuroscience, Physiology and Pharmacology, University College<br />
London London, United Kingdom<br />
Gene-targeted deletion of a predominant voltage-dependent<br />
potassium channel, Kv1.3, in mitral cells of the olfactory bulb<br />
results in a gamut of phenotypic changes including a “supersmeller”<br />
ability, supernumerary axonal projections to<br />
heterogenous glomeruli, and an alternation in action potential<br />
discharge frequency. Kv1.3 is a substrate <strong>for</strong> tyrosine<br />
phosphorylation and the molecular targets <strong>for</strong> modulation by the<br />
hormone insulin have been mapped along the N- and C-termini<br />
of the channel. Our laboratory has developed awake, intranasal<br />
insulin delivery approaches that demonstrate a robust<br />
phosphorylation of the channel that is linked to the behavioral but<br />
not anatomical modifications of the knockout model. Recently<br />
the laboratory has discovered that the channel is also responsible<br />
<strong>for</strong> regulating body weight and that both diet- and geneticallyinduced<br />
obesity can be abrogated via gene-targeted deletion of the<br />
channel, or uniquely by olfactory bulbectomy that manipulates<br />
total energy expenditure. We have now recorded on acute and<br />
chronic insulin treated mice as well as diet-induced obese mice<br />
and will present an electrophysiological analysis per<strong>for</strong>med on<br />
brain slices of how metabolic state alters neuronal responses in<br />
mitral cells of the olfactory bulb. High fat diet has additionally<br />
demonstrated an anatomical loss of olfactory sensory neurons,<br />
presynaptic to the mitral cell input. Acknowledgements: This<br />
work was supported by NIH DC03387 and NIH DC00044 from<br />
the NIDCD and sabbatical award from FSU.<br />
#38 SYMPOSIUM - CHEMORECEPTION<br />
IN CONTEXT: INTERACTIONS WITH<br />
ENDOCRINE SYSTEMS AND METABOLIC STATE<br />
Roles of taste signaling molecules in endocrine cells in pancreas<br />
and tongue<br />
Zaza Kokrashvili, Peihua Jiang, Bedrich Mosinger, Robert F.<br />
Margolskee<br />
Monell Chemical Senses Center Philadelphia, PA, USA<br />
Ga-gustducin, T1r receptors and other taste signaling elements<br />
are expressed in duodenal enteroendocrine L cells that express<br />
insulinotropic glucagon-like peptide 1 (GLP-1). Gustducin and<br />
T1r3, well known <strong>for</strong> their roles in taste signaling, are essential <strong>for</strong><br />
L cell release of GLP-1 in response to glucose. We examined taste<br />
cells to determine if they too expressed hormones typical of<br />
intestinal enteroendocrine cells. Taste cells were found to express<br />
GLP-1, glucagon, PYY and other gut hormones. Patterns of<br />
expression indicated that gustducin-expressing type II taste cells<br />
and other subtypes of taste cells express GLP-1. We also examined<br />
the function of hormones released from these “endocrine taste<br />
cells”. In wild-type mice, with or without esophagealectomy/<br />
vagotomy, application of glucose to the tongue induced a rapid<br />
elevation of GLP-1 in the bloodstream. Stimulation of taste cell<br />
explants from wild-type mice with glucose led to release of<br />
GLP-1 into the medium. Stimulation of gustducin-null mice with<br />
glucose did not lead to significant release of GLP-1 from taste<br />
cells in vivo or in explants. At least a portion of the cephalic phase<br />
rise in circulating GLP-1 depends on direct release of GLP-1 from<br />
taste cells into the bloodstream and requires gustducin. Taste<br />
receptors, Ga-gustducin and downstream proteins were also<br />
found to be expressed in several types of pancreatic islet cells.<br />
Ga-gustducin is expressed in alpha cells, and T1R3 is expressed<br />
in alpha and beta cells. Functional assays showed that in wild<br />
type mice, but not in T1R3 null mice, T1R3 receptors mediate<br />
increased secretion of insulin in response to artificial sweeteners<br />
and sweet tasting amino-acids. Acknowledgements: Supported by<br />
NIH grants DC03055 and DC03155 to RFM<br />
#39 SYMPOSIUM - CHEMORECEPTION<br />
IN CONTEXT: INTERACTIONS WITH<br />
ENDOCRINE SYSTEMS AND METABOLIC STATE<br />
Mechanisms of alimentary chemosensation and modulation<br />
C. Shawn Dotson 1 , Amanda E.T. Elson 2 , Steven D. Munger 2<br />
1<br />
Department of Neuroscience & Center <strong>for</strong> Smell and Taste,<br />
University of Florida College of Medicine Gainesville, FL, USA,<br />
2<br />
Department of Anatomy & Neurobiology, University of<br />
Maryland School of Medicine Baltimore, MD, USA<br />
Chemosensory cells throughout the alimentary canal use a<br />
common molecular toolkit to detect and respond to nutrients and<br />
other chemostimuli. For example, “taste” transduction molecules<br />
(e.g., TAS1R and TAS2R receptors, gustducin) regulate hormonal<br />
secretion in the gut. We have reported that a loss-of-function<br />
variant of a human TAS2R is associated with glucose<br />
dysregulation and the presence of Type 2 diabetes mellitus in a<br />
human population. Furthermore, bitter-tasting compounds can<br />
18 | AChemS <strong>Abstracts</strong> 2010<br />
<strong>Abstracts</strong> are printed as submitted by the author(s)